APA (7th ed.) Citation

Scantlebery, A. M. L., Uil, M., Butter, L. M., Poelman, R., Claessen, N., Girardin, S. E., . . . Leemans, J. C. (2019). NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin. PloS one, 14(3), e0214437. https://doi.org/10.1371/journal.pone.0214437

Chicago Style (17th ed.) Citation

Scantlebery, Angelique M. L., Melissa Uil, Loes M. Butter, Renée Poelman, Nike Claessen, Stephen E. Girardin, Sandrine Florquin, Joris J. T. H. Roelofs, and Jaklien C. Leemans. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced by Multiple Low Doses of Streptozotocin." PloS One 14, no. 3 (2019): e0214437. https://doi.org/10.1371/journal.pone.0214437.

MLA (9th ed.) Citation

Scantlebery, Angelique M. L., et al. "NLRX1 Does Not Play a Role in Diabetes nor the Development of Diabetic Nephropathy Induced by Multiple Low Doses of Streptozotocin." PloS One, vol. 14, no. 3, 2019, p. e0214437, https://doi.org/10.1371/journal.pone.0214437.